Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Medical Dynamic MarketingFRA:JMD 77 ROC (Joel Greenblatt) % is 1.50% as of Mar. 2026, which is 86% below its 10-year median of 10.71. GuruFocus rates FRA:JMD with a GF Score™ of 77/100 and a GF Value™ of €3.36. The stock has 12 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Japan Medical Dynamic Marketing ranks worse than 51.67% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Japan Medical Dynamic Marketing's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.50%.
The historical rank and industry rank for Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:JMD'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1.08 Med: 10.71 Max: 14.76
Current: 2.62
During the past 13 years, Japan Medical Dynamic Marketing's highest ROC (Joel Greenblatt) % was 14.76%. The lowest was -1.08%. And the median was 10.71%.
FRA:JMD's ROC (Joel Greenblatt) % is ranked worse than 51.67% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.145
vs FRA:JMD: 2.62
Japan Medical Dynamic Marketing (FRA:JMD) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Medical Dynamic Marketing ROC (Joel Greenblatt) % Chart
FRA:JMD vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) % falls into.
Japan Medical Dynamic Marketing ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 1.50% mean?
Japan Medical Dynamic Marketing (FRA:JMD) has a ROC (Joel Greenblatt) % of 1.50% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Japan Medical Dynamic Marketing and its competitors. This is 86% below median its historical median of 10.71. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 51.7%.
Is Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) % too high?
Japan Medical Dynamic Marketing's current ROC (Joel Greenblatt) % of 1.50% is 86% below median its 10-year median of 10.71. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.15. Japan Medical Dynamic Marketing's value of 1.50% is 63.8% below this industry median. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 838 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #433 out of 838 companies for ROC (Joel Greenblatt) %. This places Japan Medical Dynamic Marketing in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.15. Japan Medical Dynamic Marketing's value of 1.50% is 63.8% below this benchmark. While the company's 10-year median is 10.71 vs. the industry median of 4.15, Japan Medical Dynamic Marketing has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.15, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current ROC (Joel Greenblatt) % of 1.50% is 63.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current ROC (Joel Greenblatt) % is 1.50%, which is 86% below median its own 10-year median of 10.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current ROC (Joel Greenblatt) % of 1.50%. The stock's GF Value™ is €3.36, compared to a current price of €5.05 — trading 50.3% above its estimated fair value. The current ROC (Joel Greenblatt) % is 1.50%, which is 86% below median its 10-year median of 10.71 and 63.8% below the Medical Devices & Instruments industry median of 4.15. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current ROC (Joel Greenblatt) % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of €5.05 is trading 50.3% above its estimated GF Value™ of €3.36.
Key valuation signals for FRA:JMD:
ROC (Joel Greenblatt) %: 1.50% (86% below median its 10-year median of 10.71)
GF Value™: €3.36 vs. price of €5.05 (50.3% above fair value)
Industry Position: 63.8% below the Medical Devices & Instruments median (#433 of 838)
No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Business Description
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score
Get the complete analysis for FRA:JMD
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JMD has been successfully added to your 
